We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
Changes in gait could prove to be an early sign of Parkinson's disease, according to a new study.
Tomorrow a new band of rain will move across mainly western Scotland, further south it will stay bright with some sunny spells.
Paul Cantlie, 80, died from "complications following pneumonia" days after making an emotional plea for his son to be released.